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affected; this prevalence is in line with those reported in 
more recent studies from other countries [8–12].
Family physicians (FPs) can be regarded as experts 
in dealing with both comorbidity and multimorbidity 
in primary care; parallel to the expertise of geriatri-
cians in secondary care. It is a logical assumption that 
empiricism and experience will yield original and inno-
vative approaches to inform patient care. For this reason, 
we performed a series of studies to evaluate primary 
healthcare data and the experiences of FPs in managing 
comorbidity and multimorbidity [13–18]. The following 
is a summary of some of our findings and experiences 
where our use of the term comorbidity was aligned with 
the recent definition provided by Ramond-Roquin and 
Fortin: “comorbidity refers to an additional condition(s) 
in an individual who has a given index disease…” [3].
Patterns of comorbidity: a case study of 
diabetes mellitus
The high prevalence of multimorbidity in the population 
can often mean that patient-group- or disease-specific 
patterns are concealed. We analysed the prevalence and 
incidence density of chronic comorbid diseases in a rep-
resentative primary healthcare cohort of patients with 
recently diagnosed type 2 diabetes mellitus [13].
As expected, a high proportion of this cohort had 
chronic health problems other than diabetes: hyperten-
sion (38%) and chronic venous insufficiency (21%) were 
highly prevalent, as were chronic functional somatic 
symptoms (19%), hearing loss (14%), urinary inconti-
nence (13%), angina pectoris (12%), osteoarthritis of 
the knee (12%), chronic obstructive pulmonary disease 
The ageing population is marked by an increase in 
chronic health problems, raising concerns over the 
feasibility of healthcare systems and their financial capa-
bilities [1,2]. A central point here is the growing rate of 
multimorbidity, i.e. the coexistence of multiple chronic 
conditions in a given individual [3].
The concept of multimorbidity conflicts with the 
‘single- disease model’, around which healthcare, medi-
cine and health research are traditionally organized. This 
model has dominated healthcare, research and education 
for so long that it is only recently that multimorbidity is 
being presented as a demographic feature.
Multimorbidity requires a paradigm shift away from 
this single-disease model of patient management; a shift 
that is now increasingly recognized and adopted, albeit 
at a slow pace. However, the reality in primary health-
care is already somewhat different. Primary healthcare, 
in its comprehensive approach to all health problems in 
all individuals at all disease stages and phases of life, has 
a long experience in dealing with individuals experi-
encing a range of health problems [4], including chronic 
health problems as reported in the literature [5–7]. These 
reports indicate that multimorbidity is substantial, with 
about a third of the (primary healthcare) population 
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(11%), prostatic hyperplasia (10%), and atrial fibrillation/
flutter (9%). Cardiovascular diseases (CVD) accounted 
for a substantial proportion of the comorbidity, which 
is to be expected given that diabetes is a risk factor for 
ischaemic CVD. In this respect, our study confirmed 
the risk relationship between diabetes and ischaemic 
CVD. However, we found that a large proportion of 
the comorbidity was pathophysiology unrelated to the 
development of diabetes and outnumbered cardiovas-
cular comorbid conditions; a finding that has also been 
reported elsewhere [19–22]. These findings highlight 
that the diabetes population is heterogeneous in terms of 
comorbidity, and only a few patients had no comorbidity 
at all. This makes it almost impossible to characterize 
‘the typical diabetes patient’.
Types of comorbidity: concordant and 
discordant
From the findings in the diabetes cohort described 
above, we identified two types of comorbidity, concor-
dant and discordant, in line with the definition proposed 
by Piette and Kerr [23]. Concordant comorbidity is 
related to the pathophysiology of the index disease and 
shares a common treatment approach, thereby consoli-
dating patient care. In contrast, discordant comorbidity 
is unrelated to the pathophysiology of the index disease 
and does not share the same treatment approach. Instead, 
it requires separate management of the distinct dis-
eases; an approach that increases the risk of conflicting 
strategies, polypharmacy, interactions, and side effects. 
Discordant comorbidity is probably better characterized 
as multimorbidity [3].
Impact of comorbidity
Comorbidity may have an important impact on long-
term prognosis and outcome of care. We explored this 
in the cohort of patients with diabetes, using intermedi-
ate markers of outcome of care: systolic blood pressure 
(SBP) and glycaemic control (HbA1c), as defined in the 
Dutch College of General Practitioners practice guide-
lines on type 2 diabetes [24]. Surprisingly, it was not the 
number of comorbid diseases that had a negative influ-
ence on these parameters of long-term diabetes control; 
instead, it was the specific comorbidity. For example, 
patients with comorbid musculoskeletal disease had 
higher HbA1c values 5 years after the diagnosis of diabe-
tes, whereas patients with comorbid CVD had sustained 
elevated levels of SBP.
Elevated SBP was also often seen in patients with 
diabetes and comorbid chronic obstructive pulmonary 
disease (COPD) [15], a disease common in the (elderly) 
population [25] and particularly prevalent (11%) in our 
cohort of patients with diabetes [13]. In this group of 
patients with diabetes and comorbid COPD, we analysed 
the effects of socioeconomic status and body mass index 
and concluded that socioeconomic status was a strong 
determinant of an unfavourable outcome in SBP [15].
Patient care: challenges and empirical solutions
A series of focus groups were held with FPs to explore 
their experiences, approaches and strategies in their 
care of patients with multiple chronic health problems 
[16,17].
FPs experienced comorbidity as a challenge to pro-
viding optimal patient care. In particular, the combined 
presence of somatic and mental health conditions was 
perceived as a difficult combination, increasing the dif-
ficulty of diagnosis and treatment of both somatic and 
mental health conditions as symptom presentation and 
treatment adherence may be altered. One condition may 
be experienced as ‘overshadowing’ another. In general, 
comorbidity did bring with it the risk of fragmentation 
of care through separate and uncoordinated disease- 
directed interventions [16].
The Dutch College of General Practitioners has 
guidelines for a substantial number of chronic condi-
tions [26], and the application of these guidelines in 
the care of patients with comorbidity was an issue for 
FPs. Although FPs were positive about the professional 
guidance the guidelines offered, their general opinion 
was that guidelines alone were insufficient to address 
the needs of patients with multimorbidity and the 
associated complexity [17]. In particular, preventative 
interventions were often seen as an inappropriate bur-
den to patient care. There were more general concerns 
about the role of guidelines in prescribing the content 
of care rather than in providing advice on possible evi-
dence-based directions. FPs stressed the importance of 
an approach that combined the best available evidence 
with their clinical experience and knowledge of the 
person with the disease to optimize the management of 
multimorbidity.
In the focus group discussions, a clear strategy emerged 
of how FPs met the challenges of patients with multi-
morbidity [16,17]. Their personal relationship of trust 
built over time with the patient and family was seen as 
their operational clinical basis. First and foremost, they 
invested in this relationship and made sure that it was 
preserved, particularly when there was uncertainty or 
differences in opinion on the best treatment options. 
A person-centred approach with shared decision mak-
ing was seen as the best way to handle the pitfalls of 
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managing multimorbidity. This person-centredness 
made it possible to place intrinsic medical considerations – 
including guideline recommendations – in a broader 
individual perspective for decision making.
Conclusions and recommendations
Our studies confirm the high prevalence of multimor-
bidity in the primary healthcare setting and the variation 
in comorbid conditions between patients with the same 
index disease. For the most part, comorbid conditions 
were discordant, showing comorbidity to be a personal 
rather than a disease-related characteristic. Our find-
ings were based on type 2 diabetes mellitus as the index 
condition, and exploring the variation in comorbidities 
with other common chronic conditions is warranted.
Our findings highlight the importance of a per-
son-centred approach by FPs. This may be due to the 
fact that in coping with the clinical challenges of car-
ing for patients with multimorbidity, practice is ahead 
of science. Future research should build on the empiri-
cism that practice has built over the years: to support the 
development and maintenance of trusting relationships 
over time and decision making that shares the wisdom 
of the patient and FP professional.
This also has implications for the structure of health-
care: enabling personal relationships with patients and 
awarding working over time in response to individual 
needs. This is particularly relevant for primary health-
care as, in the community setting, health and well being 
are linked. Our data reveal that most individuals expe-
rience multiple chronic diseases. Add to that the social 
and economic problems people are facing and it is clear 
that hardly anyone can be characterized by a single 
(health) problem.
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